CATTALINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4.122
EU - Europa 3.261
AS - Asia 1.326
OC - Oceania 9
SA - Sud America 7
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.735
Nazione #
US - Stati Uniti d'America 4.107
PL - Polonia 1.590
CN - Cina 477
UA - Ucraina 448
SG - Singapore 355
FR - Francia 323
DE - Germania 270
HK - Hong Kong 235
IT - Italia 222
FI - Finlandia 128
TR - Turchia 119
GB - Regno Unito 108
IE - Irlanda 103
VN - Vietnam 70
ID - Indonesia 41
BE - Belgio 19
CA - Canada 15
IN - India 14
SE - Svezia 13
RU - Federazione Russa 11
AU - Australia 8
NL - Olanda 8
ES - Italia 6
EU - Europa 5
CZ - Repubblica Ceca 4
JP - Giappone 4
CO - Colombia 3
AM - Armenia 2
BD - Bangladesh 2
CL - Cile 2
DZ - Algeria 2
MA - Marocco 2
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
LT - Lituania 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 8.735
Città #
Warsaw 1.590
Fairfield 628
Woodbridge 514
Jacksonville 355
Houston 337
Singapore 288
Ashburn 286
Seattle 237
Hong Kong 234
Cambridge 224
Wilmington 216
Ann Arbor 206
Chandler 186
Princeton 165
Beijing 117
Istanbul 112
Dublin 103
New York 100
Helsinki 87
Nanjing 85
Dong Ket 70
Brescia 42
Shenyang 42
Jakarta 37
Nanchang 37
Des Moines 36
San Diego 36
Shanghai 34
Munich 26
Dearborn 25
Changsha 22
Hebei 22
Lancaster 21
Milan 20
Jinan 18
London 17
Tianjin 17
Brussels 16
San Francisco 16
Boardman 15
Romola 15
Assemini 14
Ningbo 14
Toronto 11
Lappeenranta 10
Phoenix 10
Rome 10
Zhengzhou 10
Verona 8
Frankfurt am Main 7
Haikou 7
Jiaxing 7
Kunming 7
Orange 7
Falkenstein 6
Barcelona 5
Como 5
Guangzhou 5
Hangzhou 5
Lanzhou 5
Adelaide 4
Arezzo 4
Augusta 4
Brno 4
Florence 4
Hyderabad 4
Islington 4
Kilburn 4
Los Angeles 4
Mountain View 4
Norwalk 4
Paris 4
Stuttgart 4
Wandsworth 4
Bogotá 3
Castano Primo 3
Castelli Calepio 3
Chiswick 3
Detroit 3
Espoo 3
Gunzenhausen 3
Kocaeli 3
Leawood 3
Leipzig 3
Napoli 3
Scarperia 3
Taiyuan 3
Taizhou 3
Tokyo 3
Acton 2
Albano Sant'Alessandro 2
Bandar Lampung 2
Blida 2
Brugnera 2
Castenedolo 2
Charleston 2
Chicago 2
Dhaka 2
Fuzhou 2
Gussago 2
Totale 6.930
Nome #
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): An open-label, phase II study 270
Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease 264
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry 261
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 254
Developing a Predictive Score for Chronic Arthritis among a Cohort of Children with Musculoskeletal Complaints - The Chronic Arthritis Score Study 249
Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: A case series 231
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 231
Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders 207
When flexibility is not necessarily a virtue: a review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children 202
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 194
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 188
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 166
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 159
Canakinumab for the treatment of autoinflammatory recurrent fever syndromes 144
The change in Ig regulation from children to adults disconnects the correlation with the 3'RR hs1.2 polymorphism 125
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. 125
Development of the autoinflammatory disease damage index (ADDI) 119
Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. 118
Profound T-cell defects in Dubowitz syndrome 116
IPSC-DERIVED NEURONS AS AN IN VITRO MODEL FOR THE STUDY OF INTERFERONOPATHIES WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT 114
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry 113
Autosomal recessive agammaglobulinemia: novel insights from mutations in Ig-beta 112
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. 112
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 110
In silico validation of the autoinflammatory disease damage index 109
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 108
Condylar asymmetry in patients with juvenile idiopathic arthritis: Could it be a sign of a possible temporomandibular joints involvement? 107
Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients 105
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 105
Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome 104
Clinical and Laboratory Features of 184 Italian Pediatric Patients Affected with Selective IgA Deficiency (SIgAD): a Longitudinal Single-Center Study 104
Cryopyrin-associated periodic syndromes in Italian Patients: Evaluation of the rate of somatic NLRP3 mosaicism and phenotypic characterization 102
Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency. 101
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra 101
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 98
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. 96
DISCRIMINATION AMONG MONOGENIC AND ACQUIRED DISEASE WITH INFLAMMATORY AND AUTOIMMUNE COMPONENT THROUGH THE IN VITRO STUDY OF SIGNAL TRANSDUCERS OF TYPE I INTERFERON 95
Differentiating PFAPA syndrome from monogenic periodic fevers. 94
The multifaceted presentation of chronic recurrent multifocal osteomyelitis: A series of 486 cases from the Eurofever international registry 94
Musculoskeletal pain in children, when hypermobility is the problem 93
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. 91
Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome 90
Aicardi Goutieres Syndrome: New Insights on a Novel Set of Inborn Errors of Immunity 89
Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra 87
Sex Differences in Pediatric Rheumatology 84
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 83
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 82
Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene 80
Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists’ lens 79
Establishment of three iPSC lines from fibroblasts of a patient with Aicardi Goutières syndrome mutated in RNaseH2B 77
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. 76
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: Analysis by the Pharmachild Safety Adjudication Committee 76
Cooperative intervention to assist children with HIV-infection in Burkina Faso: The Brescia experience during the pilot phase of the ESTHER Project. 75
Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient 69
Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX1 68
Serum amyloid protein A concentration in cryopyrin-associated periodic syndromes patients treated with interleukin-1 beta antagonist 66
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 65
Contraception in adolescents with systemic lupus erythematosus 64
Prevention of Flare Recurrences in Childhood-Refractory Chronic Uveitis: An Open-LabelComparative Study of Adalimumab Versus Infliximab 64
Pitfalls of flow cytometric analysis by dihidrorodamyne-123 in the diagnosis of chronic granulomatous disease. 59
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis 59
Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome 57
Pitfalls of flow cytometric analysis by dihydrorodamine-123 in the diagnosis of chronic granulomatous disease 56
Favourable and sustained response to anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis. 56
Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection. 56
Overview of fever of unknown origin in adult and paediatric patients 56
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 54
Intervento di Cooperazione sanitaria per l'assistenza ai bambini affetti da HIV/AIDS in Burkina Faso: l'esperienza della Clinica Pediatrica di Brescia. 49
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 43
Musculoskeletal manifestations in hereditary periodic fever syndromes 42
La PFAPA 41
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 39
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 39
iPSC-derived 3d brain organoids cultured in a bioreactor as an in vitro model for the study of microcephaly in Aicardi Goutières syndrome. 38
Reumatologia per il pediatra. Cap 43 La PFAPA 36
Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey 35
High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO) 33
Covid-19 and autoimmunity 32
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 32
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease 32
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome 29
Prevalence of cranial involvement in a cohort of Italian patients with chronic non-bacterial osteomyelitis 28
null 28
Manuale di pediatria. La pratica clinica. La dermatomiosite Giovanile e il Lupus eritematoso sistemico 27
INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry 27
Inflammatory pathways signal transducers analysis in iPSC-derived neurons and 3D cerebral organoids 26
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network 24
Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics 24
Paediatric MAS/HLH caused by a novel monoallelic activating mutation in p110δ 24
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 23
Longitudinal Characterization of Immune Response in a Cohort of Children Hospitalized with Multisystem Inflammatory Syndrome 22
EULAR-Textbook on pediatric rheumatology Chapter 11 Differential diagnosis 2: non-inflammatory causes of musculoskeletal pain 22
Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets 22
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 20
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 20
The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C) 19
Development and implementation of the AIDA International Registry for patients with Behçet's disease 19
Cardiac MRI in midterm follow-up of MISC: a multicenter study 19
Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation 19
The Role of Biologic Agents in the Management of Pediatric-Onset Noninfectious Posterior Scleritis 17
Totale 8.668
Categoria #
all - tutte 45.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.560 0 0 0 0 163 252 198 262 181 260 104 140
2020/20211.608 51 165 69 184 75 181 96 182 171 185 135 114
2021/2022727 64 104 28 55 6 39 29 59 35 86 56 166
2022/2023609 91 6 8 59 50 175 11 53 91 7 29 29
2023/2024867 53 20 92 65 25 150 30 37 250 8 17 120
2024/2025665 11 28 31 358 237 0 0 0 0 0 0 0
Totale 8.986